Balance Sheet Components

3 Months Ended

Mar. 31, 2026

4. Balance Sheet Components

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):


	March 31,		December 31,
	2026		2025
Accrued research and development expenses	$	5,301	$	3,496
Accrued general and administrative expenses		1,834		3,556
Accrued compensation and benefits		640		1,774
Lease liabilities, current portion		326		317
Total accrued expenses and other current liabilities	$	8,101	$	9,143

Accrued research and development expenses were primarily related to clinical development.